A family with hereditary cerebellar ataxia finally confirmed as Gerstmann-Sträussler-Scheinker syndrome with P102L mutation in PRNP gene

References

1. ↵
   1. Lou JS,
   2. Goldfarb L,
   3. McShane L,
   4. Gatev P,
   5. Hallett M

   (1995) Use of buspirone for treatment of cerebellar ataxia. An open-label study. Arch Neurol 52, 982–988.
2. ↵
   1. Nag N,
   2. Tarlac V,
   3. Storey E

   (2013) Assessing the efficacy of specific cerebellomodulatory drugs for use as therapy for spinocerebellar ataxia type 1. Cerebellum 12, 74–82.
3. ↵
   1. Araujo AQ

   (2013) Prionic diseases. Arq Neuropsiquiatr 71, 731–737.
4. ↵
   1. Lin SH,
   2. Jiang XM,
   3. Zhao JX,
   4. Han MF,
   5. Song XN,
   6. Xin C,
   7. et al.

   (1993) Gerstmann-Sträussler-Scheinker syndrome--clinical manifestation, pathology and immunohistochemistry of 5 patients in two generations, and experimental research on animal inoculation. J Clin Neurol, 200–202.
5. ↵
   1. Wang Y,
   2. Qiao XY,
   3. Zhao CB,
   4. Gao X,
   5. Yao ZW,
   6. Qi L,
   7. et al.

   (2006) Report on the first Chinese family with Gerstmann-Straussler-Scheinker disease manifesting the codon 102 mutation in the prion protein gene. Neuropathology 26, 429–432.
6. ↵
   1. Chi NF,
   2. Lee YC,
   3. Lu YC,
   4. Wu HM,
   5. Soong BW

   (2010) Transmissible spongiform encephalopathies with P102L mutation of PRNP manifesting different phenotypes:Clinical, neuroimaging, and electrophysiological studies in Chinese kindred in Taiwan. J Neurol 257, 191–197.
7. ↵
   1. Imran M,
   2. Mahmood S

   (2011) An overview of human prion diseases. Virol J 8, 559.
8. ↵
   1. Jansen C,
   2. Parchi P,
   3. Capellari S,
   4. Vermeij AJ,
   5. Corrado P,
   6. Baas F,
   7. et al.

   (2010) Prion protein amyloidosis with divergent phenotype associated with two novel nonsense mutations in PRNP. Acta Neuropathol 119, 189–197.
9. ↵
   1. Kraus A,
   2. Anson KJ,
   3. Raymond LD,
   4. Martens C,
   5. Groveman BR,
   6. Dorward DW,
   7. et al.

   (2015) Prion Protein Prolines 102 and 105 and the Surrounding Lysine Cluster Impede Amyloid Formation. J Biol Chem 290, 21510–21522.
10. ↵
    1. Liberski PP

    (2012) Gerstmann-Straussler-Scheinker disease. Adv Exp Med Biol 724, 128–137.